| Identification | Back Directory | [Name]
(15S,16E)-16,17,20,21-Tetradehydro-16-formyl-18,19-secoyohimban-19-oic acid methyl ester | [CAS]
5523-37-5 | [Synonyms]
Vallesiachotamine
(15S,16E)-16,17,20,21-Tetradehydro-16-formyl-18,19-secoyohimban-19-oic acid methyl ester
Indolo[2,3-a]quinolizine-3-carboxylic acid, 2-[(1E)-1-formyl-1-propen-1-yl]-1,2,6,7,12,12b-hexahydro-, methyl ester, (2S,12bS)- | [Molecular Formula]
C21H22N2O3 | [MOL File]
5523-37-5.mol | [Molecular Weight]
350.41 |
| Chemical Properties | Back Directory | [Melting point ]
247-249 °C (decomp) | [Boiling point ]
566.8±50.0 °C(Predicted) | [density ]
1.28±0.1 g/cm3(Predicted) | [pka]
17.46±0.60(Predicted) |
| Hazard Information | Back Directory | [Uses]
Vallesiachotamine, a known monoterpene indole alkaloid, possesses anti-tumor activity[1]. | [References]
[1] Paula R O Soares, et al. In vitro antiproliferative effects of the indole alkaloid vallesiachotamine on human melanoma cells. Paula R O Soares. 2012 Mar;35(3):565-71. DOI:10.1007/s12272-012-0320-7 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|